Embedded Files
대표원장 논문소개
- SCI(E) 논문 101 편, Scopus 논문 14편 등 총 115편의 국제학술지 저널에 논문 출간 등 총 170편 이상의 논문 발표
- 2015년 출간한 논문인 ‘Prediction of Long-Term Treatment Response to Selective Serotonin Reuptake Inhibitors (SSRIs) Using Scalp and Source Loudness Dependence of Auditory Evoked Potentials (LDAEP) Analysis in Patients with Major Depressive Disorder’ 논문이 영국의 생물학 및 의학 전문가들이 세계적으로 영향력 있는 생물학과 의학 논문을 선정해서 발표하는 Faculty of 1000 Biology에 선정.
- 같은 논문으로 생물학연구정보센터(BRIC) '한국을 빛내는 사람들' 선정
- 2020년 출판한 논문인’Interaction between adverse childhood experiences and polygenic risk in patients with bipolar disorder’가 세계 최고 의학 잡지인 New England Journal of Medicine (NEJM)의 Journal Watch에 주목할 논문으로 소개.
SCI(E) & Scopus급 등재
국제 학술지 게재 논문
1) Park YM(1st author), Chung YC, Lee SH, Lee KJ, Kim H, Byun YC, Lim SW, Paik JW, Lee HJ. Weight gain associated with the alpha2a-adrenergic receptor -1,291 C/G polymorphism and olanzapine treatment. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:394-397.
2) Lee HJ, Kang SG, Paik JW, Lee MS, Cho BH, Park YM, Kim W, Choi JE, Jung IK, Kim L, Lee MS. No evidence for an association between G protein beta3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia. Hum Psychopharmacol. 2007;22:501-504.
3) Kang SG, Lee HJ, Park YM, Choi JE, Han C, Kim YK, Kim SH, Lee MS, Joe SH, Jung IK, Kim L. Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:160-163.
4) Lim SW, Oh KS, Shin YC, Kang SG, Kim L, Park YM, Kim W, Lee HJ. Clinical and temperamental differences between early- and late-onset alcoholism in Korean men. Compr Psychiatry. 2008;49:94-97.
5) Park YM (1st author), Cho JH, Kang SG, Choi JE, Lee SH, Kim L, Lee HJ. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients. J Clin Pharm Ther. 2008;33:55-60.
6) Kang SG, Choi JE, Park YM, Lee HJ, Han C, Kim YK, Kim SH, Lee MS, Joe SH, Jung IK, Kim L. Val158Met polymorphism in the catechol-O- methyltransferase (COMT) gene is not associated with tardive dyskinesia in schizophrenia. Neuropsychobiology. 2008;57:22-25.
7) Kang SG, Lee HJ, Choi JE, Park YM, Park JH, Han C, Kim YK, Kim SH, Lee MS, Joe SH, Jung IK, Kim L. Association study between antipsychotics-induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia. Neuropsychobiology. 2008;57:49-54.
8) Kang SG, Choi JE, An H, Park YM, Lee HJ, Han C, Kim YK, Kim SH, Cho SN, Joe SH, Jung IK, Kim L, Lee MS. Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1844-1847.
9) Park YM (1st author), Che HJ, Im CH, Jung HT, Bae SM, Lee SH. Decreased EEG synchronization and its correlation with symptom severity in Alzheimer's disease. Neurosci Res. 2008;62:112-117.
10) Park YM (1st and Corresponding author), Lee SH, Lee HJ, Kim H, Lee KJ, Kang SG. Ziprasidone-associated mania in Korean schizophrenic patient. J Clin Psychopharmacol. 2008;28:711-713.
11) Park YM (1st and Corresponding author), Lee HJ, Kang SG, Choo CS, Cho JH. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:318-319
12) Park YM (1st author), Chung YC, Lee SH, Lee KJ, Kim H, Choi JE, Kang SG, Lee MS, Kim L, Lee HJ. G-protein β3 Subunit Gene 825C/T Polymorphism Is Not Associated with Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients. Psychiatry Investig 2009;6:49-53.
13) Lee HJ, Kang SG, Choi JE, Park YM, Lim SW, Lee MK, Kim SH, Kim L. No evidence for association between tyrosine hydroxylase gene val81met polymorphism and susceptibility to tardive dyskinesia in schizophrenia. Psychiatry Investig 2009;6:108-111
14) Cho CH, Kang SG, Choi JE, Park YM, Lee HJ, Kim L. Association between antipsychotic-induced restless legs syndrome and tyrosine hydroxylase gene polymorphism. Psychiatry Investig 2009;6:211-215.
15) Park YM (1st and Corresponding author), Lee HJ, Kang SG, Cho JH, Kim L. Resolution of pregabalin and mirtazapine associated restless legs syndrome by bupropion in a patient with major depressive disorder. Psychiatry Investig 2009;6:312-314.
16) Park YM (1st author), Lee HJ, Kang SG, Choi HS, Choi JE, Cho JH, Kim L. Prevalence of idiopathic and secondary restless legs syndrome in Korean Women. General Hospital Psychiatry 2010;32:164-168.
17) Park YM (1st author), Lee SH, Kim SR, Bae SM. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:313-316.
18) Park YM (1st and Corresponding author), Lee HJ, Kang SG, Cho JH, Lim YS, Kim L. The withdrawal from TDF therapy could induce transient RLS. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:419-420.
19) Lee SH, Park YM, Kim DW, Im CH. Global Synchronization Index as a Biological Correlate of Symptom Severity in Alzheimer’s Disease. Neurosci Res 2010;66:333-339.
20) Park YM (1st and Corresponding author), Jung YK. Manic switch and serotonin syndrome induced by augmentation of paroxetine with methylphenidate in a patient with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:719-20.
21) Bae SM, Lee SH, Park YM, Hyun MH, Yoon H. Predictive factors of social functioning in patients with schizophrenia: exploration for the best combination of variables using data mining. Psychiatry Investig. 2010;7:93-101.
22) Park YM (1st author), Lee HJ, Kang SG, Choi JE, Cho JH, Kim L. Lack of Association between Glutathione S-Transferase-M1, -T1, and -P1 Polymorphisms and Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients. Psychiatry Investig. 2010;7:147-52.
23) Kang SG, Park YM, Choi JE, Lim SW, Lee HJ, Lee SH, Kim YK, Kim SH, Cho SN, Kim L. Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia. Hum Psychopharmacol 2010;25:397-403.
24) Park YM (1st and Corresponding author), Lee BH, Lee HJ, Kang SG. Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder. Psychiatry Investig. 2010;7(3):228-30.
25) Lim HE, Lee MS, Ko YH, Park YM, Joe SH, Kim YK, Han C, Lee HY, Pedersen SS, Denollet J. Assessment of the Type D Personality Construct in the Korean Population: A Validation Study of the Korean DS 14. J Korean Med Sci. 2011;26(1):116-23.
26) Park YM (1st author), Kim DW, Kim S, Im CH, Lee SH. The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder. Psychopharmacology. 2011;213(2-3):625-32.
27) Lee HJ, Kim L, Kang SG, Yoon HK, Choi JE, Park YM, Kim SJ, Kripke DF. PER2 Variation is Associated with Diurnal Preference in a Korean Young population. Behav Genet. 2011 ;41(2):273-7.
28) Park YM (1st author), Kang SG, Choi JE, Kim YK, Kim SH, Park JY, Kim L, Lee HJ. No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients. Psychiatry Investig. 2011;8(1):49-54.
29) Park YM (1st and Corresponding author), Kang SG, Lee BH, Lee HJ. Decreased thyroid function in Korean women with bipolar disorder receiving valproic acid. Gen Hosp Psychiatry. 2011;33(2):200.e13-5.
30) Kang SG, Yoon BM, Park YM(Corresponding author). Mirtazapine-induced hepatocellular-type liver injury. Ann Pharmacother. 2011;45(6):825-6.
31) Park YM (1st author), Choi JE, Kang SG, Koo SH, Kim L, Geum D, Lee HJ. Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain. Hum Psychopharmacol. 2011;26(4-5):332-337.
32) Kang SG, Park YM (Corresponding author), Lee HJ, Yoon B. Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder. Psychiatry Investig. 2011;8(3):269-71.
33) Park YM (1st and Corresponding author), Lee SH, Park EJ. Usefulness of LDAEP to predict tolerability to SSRIs in major depressive disorder: case report. Psychiatry Investig. 2012;9:80-82.
34) Lee BH, Kang SG, Kim TW, Lee HJ, Yoon HK, Park YM (Corresponding author). Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients. Psychiatry Clin Neurosci. 2012;66:69-73.
35) Il-Soo Kim, Ho-Kyoung Yoon, Seung-Gul Kang, Young-Min Park, Yong-Ku Kim, Seung-Hyun Kim, Jung-Eun Choi, Leen Kim and Heon-Jeong Lee. No Association between PAWR Gene Polymorphisms and Tardive Dyskinesia in Schizophrenia Patients. Psychiatry Investig. 2012;9:191-194.
36) Lee KS, Lee SH, Park YM. Serotonergic Dysfunction in Patients with Bipolar Disorder Assessed by the Loudness Dependence of the Auditory Evoked Potential. Psychiatry Investig. 2012;9:298-306.
37) Park YM (1st and Corresponding author). Prolonged Drug-Drug Interaction between Terbinafine and Perphenazine. Psychiatry Investig. 2012;9(4):422-4.
38) Min JA, Lee SH, Lee SY, Chae JH, Lee CU, Park YM, Bae SM. Clinical characteristics associated with different strengths of loudness dependence of auditory evoked potentials (LDAEP) in major depressive disorder. Psychiatry Res. 2012;200(2-3):374-81.
39) Jung YE, Min JA, Shin AY, Han SY, Lee KU, Kim TS, Park JE, Choi SW, Lee SH, Choi KS, Park YM, Woo JM, Bhang SY, Kang EH, Kim W, Yu JJ, Chae JH; Positiveness Research Team of Korea. The Korean version of the Connor-Davidson Resilience Scale: an extended validation. Stress Health. 2012 Oct;28(4):319-26.
40) Kim DH, Park YM (Corresponding author). The association between suicidality and serotonergic dysfunction in depressed patients. J Affect Disord. 2013;148(1):72-6.
41) Park YM (1st author), Lee SH, Lee HJ, Kang SG, Min JA, Chae JH. Association between BDNF gene polymorphisms and serotonergic activity using loudness dependence of auditory evoked potentials in healthy subjects. PLoS One. 2013;8(4):e60340.
42) Park YM (1st and Corresponding author), Lee SH. Can the Loudness Dependence of Auditory Evoked Potentials and Suicidality Be Used to Differentiate between Depressive Patients with and without Bipolarity. Psychiatry Investig. 2013;10(2):143-7.
43) Kang SG, Lee HJ, Park YM, Yang HJ, Song HM, Lee YJ, Cho SJ, Cho SN, Kim L. The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia. Hum Psychopharmacol. 2013 Mar;28(2):117-23.
44) Min JA, Lee HJ, Lee SH, Park YM, Kang SG, Chae JH. Gender-specific effects of brain-derived neurotrophic factor Val66Met polymorphism and childhood maltreatment on anxiety. Neuropsychobiology. 2013;67(1):6-13.
45) Kang SG, Lee HJ, Yoon HK, Cho SN, Park YM, Kim L.There is no evidence for an association between the serotonin receptor 3A gene C178T polymorphism and tardive dyskinesia in Korean schizophrenia patients. Nord J Psychiatry. 2013 Jun;67(3):214-8.
46) Park YM (1st and Corresponding author), Lee SH. Clinical usefulness of loudness dependence of auditory evoked potentials (LDAEP) in patients with bipolar disorder. Psychiatry Investig. 2013;10:233-237.
47) Kim S, Park YM (Corresponding author). Serum prolactin and macroprolactin levels among outpatients with major depressive disorder following the administration of selective serotonin-reuptake inhibitors: a cross-sectional pilot study. PLoS One. 2013;8:e82749.
48) Park YM (Corresponding author), Kim YS. Secondary mania in a patient with delayed anoxic encephalopathy after carbon monoxide intoxication caused by a suicide attempt. Gen Hosp Psychiatry. 2014;36:125.e3-4.
49) Lim HE, Lee MS, Ko YH, Park YM, Han C Joe SH. Distressed personality without a partner enhances the risk of depression in patients with coronary heart disease. Asia Pac Psychiatry 2013;5:284-292.
50) Park YM (1st and Corresponding author). Low-Dose Manic Switch and High-Dose Antimanic Effect and Extrapyramidal Symptoms by Aripiprazole in a Single Bipolar Patient. Am J Ther 2014;21:e218-220.
51) Park YM (1st and Corresponding author). Relationship between SSRI-induced sexual dysfunction and central serotonergic activity based on the loudness dependence of auditory evoked potentials. Psychopharmacology (Berl) 2014;231:551-555.
52) Son WY, Lee HJ, Yoon HK, Kang SG, Park YM, Yang HJ, et al. Gaba transporter SLC6A11 gene polymorphism associated with tardive dyskinesia. Nord J Psychiatry 2014;68:123-128.
53) Kang SG, Lee YJ, Kim SJ, Lim W, Lee HJ, Park YM, Cho IH, Cho SJ, Hong JP. Weekend catch-up sleep is independently associated with suicide attempts and self-injury in Korean adolescents. Compr Psychiatry. 2014;55:319-325.
54) Wang HR, Bahk WM, Park YM, Lee HB, Song HR, Jeong JH, Seo JS, Lim ES, Hong JW, Kim W, Jon DI, Hong JP, Woo YS, Min KJ. Korean medication algorithm for depressive disorder: comparisons with other treatment guidelines. Psychiatry Investig. 2014;11:1-11.
55) Park YM (1st and Corresponding author), Lee BH, Lee SH. The association between serum lipid levels, suicide ideation, and central serotonergic activity in patients with major depressive disorder. J Affect Disord. 2014;159:62-65.
56) Park YM (1st and Corresponding author), Lee BH, Um TH, Kim S. Serum BDNF levels in relation to illness severity, suicide attempts, and central serotonin activity in patients with major depressive disorder: a pilot study. PLoS One. 2014;9:e91061.
57) Park YM (1st and Corresponding author), Park HK, Kim L, Lee HJ, Kang SG. Acute-withdrawal restless legs syndrome following abrupt cessation of short-term tramadol. Psychiatry Investig. 2014;11:204-206.
58) Lee BH, Park YM (Corresponding author), Um TH, Kim S. Lower serum BDNF levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment. Neuropsychiatric disease and treatment. 2014;23:1393-1398.
59) Jung JS, Lee HJ, Cho CH, Kang SG, Yoon HK, Park YM, Moon JH, Yang HJ, Song HM, Kim L. Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphisms in schizophrenia. Chronobiol Int. 2014;31:838-844.
60) Seok Seo J, Rim Song H, Bin Lee H, Park YM, Hong JW, Kim W, Wang HR, Lim ES, Jeong JH, Jon DI, Joon Min K, Sup Woo Y, Bahk WM. The Korean Medication Algorithm for Depressive Disorder: second revision. J Affect Disord. 2014;167:312-321.
61) Park YM (1st and Corresponding author), Ko YH, Lee MS, Lee HJ, Kim L. Type-d personality can predict suicidality in patients with major depressive disorder. Psychiatry Investig. 2014;11:232-236.
62) Park EJ, Park YM (Corresponding author). The Short-Term Effects of Risperidone-Induced Hyperprolactinemia on Lipid Metabolism in Drug-Naïve Children and Adolescents. Psychiatry Investig. 2015;12:55-60.
63) Lee BH, Park YM (Corresponding author), Lee SH, Shim M. Prediction of long-term treatment response to selective serotonin reuptake inhibitors (SSRIs) using scalp and source loudness dependence of auditory evoked potentials (LDAEP) analysis in patients with major depressive disorderInt J Mol Sci. 2015 Mar 18;16(3):6251-65.
64) Kim HI, Lee HJ, Cho CH, Kang SG, Yoon HK, Park YM, Lee SH, Moon JH, Song HM, Lee E, Kim L. Association of CLOCK, ARNTL, and NPAS2 gene polymorphisms and seasonal variations in mood and behavior. Chronobiol Int. 2015 Jul;32(6):785-91
65) Park YM (1st and Corresponding author). Relationship between Serotonergic Dysfunction Based on Loudness Dependence of Auditory-Evoked Potentials and Suicide in Patients with Major Depressive Disorder. Psychiatry Investigation. 2015;12(4):421-424
66) Park YM (1st author), Jung E, Kim HS, Hahn SW, Lee SH. Differences in central serotoninergic transmission among patients with recent onset, sub-chronic, and chronic schizophrenia as assessed by the loudness dependence of auditory evoked potentials. Schizophr Res. 2015;168(1-2):180-184
67) Lee BH, Park YM(Corresponding author). How childhood maltreatment is related to bipolarity and central serotonergic activity in patients with major depressive disorder: a cross-sectional pilot study. Psychiatry Investigatgion. 2016;13(2):190-195
68) Park YM (1st and Corresponding author), Shin HW. Zolpidem induced sleep-related eating and complex behaviors in a patient with obstructive sleep apnea and restless legs syndrome. Clinical Psychopharmacology and Neuroscience. 2016;14(3):299-301.
69) Park YM (1st author), Lee SH, Lee BH, Lee KY, Lee KS, Kang SG, Lee HY, Kim Won. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: a preliminary study. Psychiatry Research. 2016;239:184-189
70) Park YM (1st and Corresponding author), Lee BH. Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: A post-hoc data analysis (KOMDD study). Neuropsychiatric Disease and Treatment. 2016;12:1221-7.
71) Woo YS, Park JE, Kim DH, Sohn I, Hwang TY, Park YM, Jon DI, Jeong JH, Bahk WM. Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation? An Open-Label, Prospective, Multicenter Study. Psychiatry Investig. 2016;13(4):458-67.
72) Woo YS, Bahk WM, Park YM, Chung S, Yoon BH, Won S, Lee JG, Lee HB, Kim W, Jeong JH, Lee K, Kim MD. Effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder. Int Clin Psychopharmacol. 2016;31(5):275-86.
73) Moon JH, Cho CH, Son GH, Geum D, Chung S, Kim H, Kang SG, Park YM, Yoon HK, Kim L, Jee HJ, An H, Kripke DF, Lee HJ. Advanced Circadian Phase in Mania and Delayed Circadian Phase in Mixed Mania and Depression Returned to Normal after Treatment of Bipolar Disorder. EBioMedicine. 2016;11:285-295.
74) Song HM, Cho CH, Lee HJ, Moon JH, Kang SG, Yoon HK, Park YM, Kim L. Association of CLOCK, ARNTL, PER2, and GNB3 polymorphisms with diurnal preference in a Korean population. Chronobiol Int. 2016;33(10):1455-1463.
75) Kang SG, Yoon HK, Cho CH, Kwon S, Kang J, Park YM, Lee E, Kim L, Lee HJ.
Decrease in fMRI brain activation during working memory performed after sleeping
under 10 lux light. Sci Rep. 2016 Nov 9;6:36731.
76) Park YM (1st and Corresponding author). Relationship between Childhood Maltreatment, Suicidality, and Bipolarity: A Retrospective Study. Psychiatry Investig. 2017 Mar;14(2):136-140.
77) Park YM (1st and Corresponding author). Serum Prolactin Levels in Patients with Major Depressive Disorder Receiving Selective Serotonin-Reuptake Inhibitor Monotherapy for 3 Months: A Prospective Study. Psychiatry Investig. 2017 May;14(3):368-371.
78) Wang HR, Bahk WM, Seo JS, Woo YS, Park YM, Jeong JH, Kim W, Shim SH, Lee JG, Jon DI, Min KJ. Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines. Clin Psychopharmacol Neurosci. 2017 Aug 31;15(3):199-209.
79) Min JA, Lee HJ, Lee SH, Park YM, Kang SG, Park YG, Chae JH. RORA Polymorphism Interacts with Childhood Maltreatment in Determining Anxiety Sensitivity by Sex: A Preliminary Study in Healthy Young Adults. Clin Psychopharmacol Neurosci. 2017 Nov 30;15(4):402-406.
80) Cho CH, Choi JH, Kang SG, Yoon HK, Park YM, Moon JH, Jung KY, Han JK, Shin HB, Noh HJ, Koo YS, Kim L, Woo HG, Lee HJ. A Genome-Wide Association Study Identifies UTRN Gene Polymorphism for Restless Legs Syndrome in a Korean Population. Psychiatry Investig. 2017 Nov;14(6):830-838.
81) Seo JS, Bahk WM, Wang HR, Woo YS, Park YM, Jeong JH, Kim W, Shim SH, Lee JG, Jon DI, Min KJ. Korean Medication Algorithm for Depressive Disorders 2017: Third Revision. Clin Psychopharmacol Neurosci. 2018 Feb 28;16(1):67-87.
82) Kang SG, Lee YJ, Park YM, Kim L, Lee HJ. Haplotype Association of the MAP2K5 Gene with Antipsychotics-Induced Symptoms of Restless Legs Syndrome among Patients with Schizophrenia. Psychiatry Investig. 2018 Jan;15(1):84-89.
83) Park YM (1st and Corresponding author). The Mixed-Features Specifier of Major Depressive Disorder in DSM-5: Is It Practical? Psychiatry Investig. 2018 Nov;15(11):1009-1010.
84) Park YM (1st and Corresponding author), Lee BH. Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder. Psychiatry Investig. 2018 Aug;15(8):818-823.
85) Lee BH, Park YM (Corresponding author), Lee SH, Shim M. Serum Levels of Tumor Necrosis Factor-α and Loudness Dependence of Auditory Evoked Potentials at Pretreatment and Posttreatment in Patients with Major Depressive Disorder. Brain Sci. 2019 Sep 26;9(10):253.
86) Park YM (1st and Corresponding author). Chronotype Is Associated with Emotional Dysregulation Influenced by Childhood Trauma: A Retrospective Study Chronobiol Med. 2019;1(1):21-25.
87) Park YM (1st and Corresponding author). Zolpidem-Induced Sleep-Related Eating Disorder. Chronobiol Med. 2019;1(3):111-114.
88) Park YM (1st and Corresponding author). Restless Legs Syndrome Caused by Quetiapine. Chronobiol Med. 2020;2(1):21-24.
89) Park EJ, Park YM (Corresponding author). Melatonin and Sleep Problems in Children with Autism Spectrum Disorder. Chronobiol Med. 2020;2(2):47-51.
90) Park EJ, Park YM (Corresponding author). Opioid Withdrawal and Restless Legs Syndrome. Chronobiol Med. 2020;2(4):137-140.
91) Park HK, Lee JJ, Park YM (Corresponding author). Preserved Serotonergic Activity in Early-Onset Parkinson's Disease. Can J Neurol Sci. 2020 May;47(3):344-349.
92) Park YM (1st and Corresponding author). The Hypothesis on the Prediction of Treatment Response with Buspirone Augmentation along with Serotonergic Antidepressant in Patients with Major Depressive Disorder Using Loudness Dependence of Auditory Evoked Potentials: Two Cases and Review of the Literature for Evidence. Psychiatry Investig. 2020 Mar;17(3):222-224.
93) Park YM (1st and Corresponding author), Shekhtman T, Kelsoe JR. Effect of the Type and Number of Adverse Childhood Experiences and the Timing of Adverse Experiences on Clinical Outcomes in Individuals with Bipolar Disorder. Brain Sci. 2020 Apr 27;10(5):E254
94) Kim YR, Park YM (Corresponding author). Mismatch Negativity and Loudness Dependence of Auditory Evoked Potentials among Patients with Major Depressive Disorder, Bipolar II Disorder, and Bipolar I Disorder. Brain Sci. 2020 Oct 28;10(11):789.
95) Park YM (1st and Corresponding author). Relationship between Auditory Evoked Potentials and Circadian Preference in Patients with Major Depressive Episodes. Brain Sci. 2020 Jun 12;10(6):370.
96) Park YM (1st and Corresponding author), Shekhtman T, Kelsoe JR. Interaction between adverse childhood experiences and polygenic risk in patients with bipolar disorder. Transl Psychiatry. 2020 Sep 22;10(1):326.
97) Park YM (1st and Corresponding author). Clinical Utility of Polygenic Risk Score in Sleep Disorder. Chronobiol Med. 2021;3(2):57-59.
98) Hwang DY, Kim YR, Park YM (Corresponding author). Association Between Frontal Alpha Asymmetry With Cognitive Symptoms, Depression Severity, and Insomnia. Chronobiol Med. 2021;3(4):157-162.
99) Lee BH, Park YM, Hwang JA, Kim YK. Variable alterations in plasma erythropoietin and brain-derived neurotrophic factor levels in patients with major depressive disorder with and without a history of suicide attempt. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110324.
100) Seo JS, Bahk WM, Woo YS, Park YM, Kim W, Jeong JH, Shim SH, Lee JG, Jang SH, Yang CM, Wang SM, Jung MH, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ. Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive Summary. Clin Psychopharmacol Neurosci. 2021 Nov 30;19(4):751-772.
101) Woo YS, Bahk WM, Seo JS, Park YM, Kim W, Jeong JH, Shim SH, Lee JG, Jang SH, Yang CM, Wang SM, Jung MH, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ. The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines. Clin Psychopharmacol Neurosci. 2022 Feb 28;20(1):37-50.
102) Park YM (1st and Corresponding author). Circadian Rhythm and Polygenic Risk Scores. Chronobiol Med. 2022;4(1):21-23.
103) Park YM (1st author). Lee SJ, Lee JS, Na KS, Kang SG, Yoon HK, Kim EJ. Prescribing Practices of Hypnotics for Elderly Patients With Insomnia at Six University Hospitals. Chronobiol Med. 2022;4(4):173-176.
104) Park EJ, Park YM, Lee SH, Kim B. The Loudness Dependence of Auditory Evoked Potentials is associated with the Symptom Severity and Treatment in Boys with Attention Deficit Hyperactivity Disorder. Clin Psychopharmacol Neurosci. 2022 Aug 31;20(3):514-525.
105) Kang H, Yoon BH, Bahk WM, Woo YS, Kim W, Lee J, Sohn I, Park SY, Jon DI, Jung MH, Kim MD, Jung YE, Sung HM, Park YM, Lee JG, Lee SY, Jang SH, Lim ES, Shim IH, Lee K, Jang SH. Psychometric Properties of the Korean Version of Functioning Assessment Short Test in Bipolar Disorder. Clin Psychopharmacol Neurosci. 2023 Feb 28;21(1):188-196.
106) Jang SH, Bahk WM, Woo YS, Seo JS, Park YM, Kim W, Jeong JH, Shim SH, Lee JG, Jon DI, Min KJ. The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions. J Clin Med. 2023 Feb 1;12(3):1146.
107) Park SY, Park YM (Corresponding author). Rifampin - Risperidone and Divalproex Drug-drug Interaction: A Case Report. Clin Psychopharmacol Neurosci. 2023;21(2):391-394.
108) Cho Y, Park YM (Corresponding author), Shim M, Lee SH. Relationship between Loudness Dependence of Auditory-evoked Potentials and Suicidality. Clin Psychopharmacol Neurosci. 2023;21(4):742-748.
109) Park YM (1st author), Lee SJ , Lee JS, Na KS, Kang SG, Lee BH, Yoon HK, Kim EJ. Efficacy of ProlongedRelease Melatonin Administration in Elderly Patients With Treatment Resistant Insomnia: A Post-Hoc Analysis. Chronobiol Med. 2023;5(4):172-177.
110) Chae B, Park YM, Lee SJ, Lee JS, Kang SG, Na KS, Kim EJ, Yoon HK. The Impact of Melatonin on Inflammatory Status and Quality of Life. Chronobiol Med. 2023;5(4):190-193.
111) Lee HJ, Park YM (Corresponding author), Shim M. Differences in Fuctional Connectivity between Patients with depression with and without Nonsuicidal Self-injury. Clin Psychopharmacol Neurosci. 2024 (in press).
112) Park SY, Park YM (Corresponding author), Kim YR. A Comparative Investigation of Functional Connectivity Utilizing Electroencephalography in Insomnia Patients With and Without Restless Leg Syndrome. Clin Psychopharmacol Neurosci. 2024 (in press).
113) Hong SY, Park YM (Corresponding author), Park EJ. Non suicidal Selfinjury and Quantified Electroencephalogram in Adolescents and Young Adults with Depression. Clin Psychopharmacol Neurosci. 2024 (in press).
114) Park YM (1st and Corresponding author). Difference between Quantitative Electroencephalography, Loudness Dependence of Auditory Evoked Potential, and Mismatch Negativity between a Manic and a Depressive Episode in a Single Bipolar Patient with Mixed Features. Clin Psychopharmacol Neurosci. 2024 (in press).
115) Park YM (1st and Corresponding author). Alteration of Functional Connectivity before and after Electroconvulsive Therapy in a Single Patient with Depression and Catatonia. Clin Psychopharmacol Neurosci. 2024 (in press).
Page updated
Google Sites
Report abuse